Prawo i regulacje · 25/01/2013

Myoderm Submits Notice of Registration for Controlled Substance Importation

Myoderm, a pharmaceutical company, has submitted a notice of registration with the U.S. government to import controlled substances for medical use. The company aims to bring Myoderm, a treatment for skin conditions, to the U.S. market.